Martin D. Madaus - Director at Repligen Corp

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
RGEN on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Martin D. Madaus - trading volume in the past year for Repligen Corp

Holdings reported by Martin D. Madaus for Repligen Corp

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 4,613 $579 K $125.46 Jun 14, 2024 Direct
Common Stock 11 $1.38 K $125.46 Jun 14, 2024 Spouse Trust
Stock Option (Right to Buy) 1,376 May 16, 2024 Direct Common Stock

Transactions reported by Martin D. Madaus for Repligen Corp

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership